EMA Authorised: Akynzeo (netupitant;palonosetron hydrochloride) — Helsinn Birex Pharmaceuticals Ltd

View source ↗

Summary

The EMA authorised Akynzeo (netupitant and palonosetron hydrochloride) for vomiting, nausea, cancer-related indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Nausea
• Neoplasms
• Vomiting

Drugs mentioned

• Akynzeo (netupitant/palonosetron)
• Netupitant (netupitant)
• Palonosetron hydrochloride (Palonosetron hydrochloride)

Snippet

Status: Authorised. Therapeutic area: Vomiting;Neoplasms;Nausea;Cancer. MAH: Helsinn Birex Pharmaceuticals Ltd. Decision date: 25/08/2026